Magnesium in biology be used as adjuvant therapy in patients on optimal treatment for severe congestive heart failure, increasing survival rate and improving clinical symptoms and patient's quality of life. Magnesium can affect muscle relaxation through direct action on cell membranes. Mg ions close certain types of calcium channels, which conduct positively charged calcium ions into neurons. With an excess of magnesium, more channels will be blocked and nerve cells activity will decrease. Intravenous magnesium sulphate is used in treating pre-eclampsia. For other than pregnancy-related hypertension, a meta-analysis of 22 clinical trials with dose ranges of 120 to 973 mg/day and a mean
Low valent magnesium compounds Low valent magnesium compounds A number of stable low valent magnesium compounds containing a metal-metal, Mg-Mg, bond, where magnesium exhibits the formal oxidation state of +1 are known. These compounds generally have the formula LMg, where L represents a bulky ligand. The first examples of these stable magnesium(I) compounds were reported in 2007. The chemistry of Mg is dominated by the +2 oxidation state and prior to 2007 only examples of crystalline compounds with short Mg-Mg distances that may indicate an Mg-Mg bond were known, such as the ternary metal hydrides MgRuH, MgRuH, and MgIrH and magnesium diboride, Calculations had